A Prospective, Multi-site, Randomized, Sham-Controlled, Double-Blind Trial With One-Way Crossover Designed to Assess the Effectiveness and Safety of the Gimer NeuroBlock SCS Trialing System for the Treatment of Chronic Back Pain and/or Lower Limb Pain

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

February 1, 2022

Study Completion Date

April 1, 2022

Conditions

Chronic PainLow Back PainLower Limb Pain

Interventions

DEVICE

NeuroBlock UHF stimulation

NeuroBlock ultrahigh frequency (UHF) stimulation with 500kHz intra-pulse

Trial Locations (4)

China Medical University Hospital, Taichung

Mackay Memorial Hospital, Taipei

National Taiwan University Hospital, Taipei

Veterans General Hospital-Taipei, Taipei